FGFR3, as a receptor tyrosine kinase, is associated with differentiated biological functions and improved survival of glioma patients

BACKGROUND: Activation of receptor tyrosine kinases is common in Malignancies. FGFR3 fusion with TACC3 has been reported to have transforming effects in primary glioblastoma and display oncogenic activity in vitro and in vivo. We set out to investigate the role of FGFR3 in glioma through transcripto...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Wang, Zheng, Zhang, Chuanbao, Sun, Lihua, Liang, Jingshan, Liu, Xing, Li, Guanzhang, Yao, Kun, Zhang, Wei, Jiang, Tao
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5356683/
https://ncbi.nlm.nih.gov/pubmed/27829236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13139
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars